Skip to main content
. 2004 Nov;48(11):4286–4292. doi: 10.1128/AAC.48.11.4286-4292.2004

FIG. 2.

FIG. 2.

T. cruzi-specific immunoglobulin G antibodies in the sera of dogs in the infected control group and dogs treated with 1.5 mg of albaconazole (UR-9825) per kg of body weight for 60 (A) or 90 (B) days or with 7 mg of benznidazole per kg divided into two daily doses for 60 days. IC, infected nontreated controls; BzT−, dogs treated with benznidazole with negative hemoculture and PCR test results; ALB+, dogs treated with albaconazole with positive hemoculture and PCR test results; ALB−, dogs treated with albaconazole with negative hemoculture and PCR test results. Data represent means ± standard deviations.